Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

NCT07214311 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Prosthetic-joint Infection

Interventions

DRUG: PLG0206
DRUG: Placebo

Sponsor

Peptilogics